Lease (Details) - USD ($) |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2025 |
May 31, 2025 |
Dec. 31, 2024 |
May 31, 2024 |
Dec. 31, 2023 |
|
| Leases [Line Items] | |||||
| Weighted average remaining lease term | 2 months 12 days | 1 year 2 months 12 days | 1 year 10 months 24 days | ||
| Operating lease weighted average discount rates | 8.00% | 8.00% | 8.00% | ||
| Impairment loss of right-of-use assets | $ 144,051 | $ 200,916 | |||
| Lease cost | $ 53,894 | 317,566 | |||
| DiamiR Biosciences Corp. [Member] | |||||
| Leases [Line Items] | |||||
| Weighted average remaining lease term | 1 year 7 months 6 days | 1 year 7 months 6 days | |||
| Operating lease weighted average discount rates | 10.00% | 10.00% | |||
| Lease term | 1 year | ||||
| Lease term renewal | 1 year | 1 year | |||
| Lease cost | $ 40,103 | $ 47,493 | |||
| Office [Member] | |||||
| Leases [Line Items] | |||||
| Impairment loss of right-of-use assets | $ 31,030 | ||||